Skip to content

Sleep Study in Adult Patients With Major Sickle Cell Disease With Paroxysmal Nocturnal Events

Sleep Study in Adult Patients With Major Sickle Cell Disease With Paroxysmal Nocturnal Events

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02539771
Acronym
DREPASOM
Enrollment
114
Registered
2015-09-03
Start date
2014-09-17
Completion date
2019-04-10
Last updated
2023-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sickle Cell Disease

Keywords

vaso-occlusive crisis, obstructive sleep apnea, priapism

Brief summary

Hypothesis is that the occurrence of nocturnal Vaso-Occlusive Crisis (VOC) and priapism in adults might be related to episodes of nocturnal desaturation secondary to a sleep apnea syndrome. Investigator hypothesize that chronic biological consequences of Obstructive Sleep Apnea (hypercoagulability, endothelial dysfunction ...) favour VOC and acute manifestations (nocturnal desaturation) favour nocturnal VOC. The confirmation of this hypothesis will lead investigator to propose a systematic screening of obstructive sleep apnea (OSA) in patients with nocturnal VOC. Moreover, systematic treatment of OSA in sickle cell patients could help significantly reduce the number and severity of nocturnal VOC.

Interventions

OTHERPolysomnography and blood sample

Blood collection is a specific intervention of protocol for the 3 arms. Polysomnography is a specific intervention for the arms Diurnal VOC and Slightly symptomatic

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Night VOC Group: * night VOC ≥ 2 in the previous year * written informed consent Daytime VOC Group: * VOC no nocturnal * diurnal VOC ≥ 2 in the previous year * written informed consent Slightly symptomatic group: * no hospitalization for VOC * written informed consent

Exclusion criteria

* Taking opioids * Taking medication that alters sleep (antidepressants, benzodiazepines ...) * Known history of sleep apnea syndrome * Known history of serious psychiatric disorder * Recent vaso-occlusive crisis (within 3 weeks) * Changes in background treatment (Hydrea or exchange transfusions) in the past 12 months * Inactive affiliation to social security * Under legal protection * A female who is pregnant or breastfeeding * Prisoners * Emergency situation * Refusing to participate in the study

Design outcomes

Primary

MeasureTime frame
Percentage of patients with nocturnal desaturation and patients with OSAat 1 year

Secondary

MeasureTime frame
Minimum oxygen saturation levelat 1 year
Quantitative analysis of biomarkers in plasma samplesat 1 year
Quantitative analysis of proinflammatory and anti-inflammatory cytokinesat 1 year
Oxygen desaturation indexat 1 year
Apnea-Hypopnea Indexat 1 year
Sleep time with arterial oxygen saturation less than 90%at 1 year
Minimum oxygen saturation level during rapid eye movement (REM) sleep in patients with recurrent priapism and in patients who never presented priapismat 1 year

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026